MOTS — Motus GI Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$2.64m
- $0.32m
Annual income statement for Motus GI Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.107 | 0.098 | 0.391 | 0.592 | 0.319 |
| Cost of Revenue | |||||
| Gross Profit | -0.029 | -0.398 | 0.21 | -0.204 | -0.25 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 23.5 | 19.1 | 18.6 | 18.4 | 12.5 |
| Operating Profit | -23.4 | -19 | -18.2 | -17.9 | -12.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -23.1 | -19.3 | -19 | -18.6 | -12.9 |
| Net Income After Taxes | -23.1 | -19.3 | -19 | -18.6 | -12.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -23.1 | -19.3 | -19 | -18.6 | -12.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -23.1 | -19.3 | -25.2 | -18.6 | -12.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -275 | -180 | -157 | -85.9 | -15.5 |